Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial
科研成果: 期刊稿件 › 文章 › 同行评审
14
引用
（Scopus）